Kyle Malady's most recent trade in Verizon Communications Inc was a trade of 129 Phantom Stock (unitized) done . Disclosure was reported to the exchange on May 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 129 | 417,016 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2026 | 129 | 410,898 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 127 | 410,769 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 89,087 | 89,087 | - | - | Restricted Stock Units - 2026 Award | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2026 | 120 | 410,641 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2026 | 120 | 410,521 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 34,936 | 34,936 | - | - | Restricted Stock Units - 2024 Award | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 34,936 | 113,741 (0%) | 0% | - | Common Stock | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 34,020 | 95,407 (0%) | 0% | - | Common Stock | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 34,020 | 0 | - | - | Restricted Stock Units - 2023 Award | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 31,331 | 62,662 | - | - | Restricted Stock Units - 2025 Award | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2026 | 31,331 | 128,023 (0%) | 0% | - | Common Stock | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.14 per share. | 27 Feb 2026 | 17,057 | 110,966 (0%) | 0% | 50.1 | 855,238 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.14 per share. | 27 Feb 2026 | 17,049 | 96,692 (0%) | 0% | 50.1 | 854,837 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.14 per share. | 27 Feb 2026 | 16,602 | 78,805 (0%) | 0% | 50.1 | 832,424 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 7,222 | 410,401 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 123 | 403,178 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 119,409 | 119,417 (0%) | 0% | - | Common Stock | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.97 per share. | 11 Feb 2026 | 58,030 | 61,387 (0%) | 0% | 49.0 | 2,841,729 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2026 | 84,926 | 84,926 | - | - | Special Restricted Stock Units - 2026 Award | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 152 | 396,960 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 154 | 396,807 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 149 | 396,652 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2025 | 150 | 396,503 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2025 | 146 | 396,353 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 148 | 396,206 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 152 | 396,057 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2025 | 157 | 389,164 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2025 | 148 | 389,006 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2025 | 139 | 388,858 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2025 | 137 | 388,718 | - | - | Phantom Stock (unitized) | |
| DexCom | Kyle Malady | Director | Sale of securities on an exchange or to another person at price $ 80.86 per share. | 05 Sep 2025 | 667 | 22,667 (0%) | 0% | 80.9 | 53,934 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2025 | 138 | 388,580 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2025 | 139 | 388,442 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2025 | 141 | 382,317 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2025 | 148 | 382,175 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2025 | 139 | 382,027 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 145 | 381,888 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 140 | 381,742 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 140 | 381,602 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Sale of securities on an exchange or to another person at price $ 43.81 per share. | 08 May 2025 | 9,701 | 307 (0%) | 0% | 43.8 | 425,001 | Common Stock |
| DexCom | Kyle Malady | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 5,192 | 23,334 (0%) | 0% | 0 | Common Stock | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Sale of securities on an exchange or to another person at price $ 43.82 per share. | 08 May 2025 | 299 | 8 (0%) | 0% | 43.8 | 13,101 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 139 | 381,461 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Sale of securities on an exchange or to another person at price $ 44.10 per share. | 07 May 2025 | 9,000 | 10,008 (0%) | 0% | 44.1 | 396,900 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Sale of securities on an exchange or to another person at price $ 43.88 per share. | 30 Apr 2025 | 7,500 | 19,008 (0%) | 0% | 43.9 | 329,063 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Sale of securities on an exchange or to another person at price $ 43.02 per share. | 24 Apr 2025 | 10,000 | 26,508 (0%) | 0% | 43.0 | 430,240 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2025 | 141 | 375,492 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Sale of securities on an exchange or to another person at price $ 42.48 per share. | 23 Apr 2025 | 5,000 | 36,508 (0%) | 0% | 42.5 | 212,425 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 141 | 375,350 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 134 | 375,209 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 88,176 | 88,176 | - | - | Restricted Stock Units - 2025 Award | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 138 | 375,074 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 32,774 | 65,548 | - | - | Restricted Stock Units - 2024 Award | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 32,774 | 59,646 (0%) | 0% | - | Common Stock | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 31,914 | 31,915 | - | - | Restricted Stock Units - 2023 Award | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 31,914 | 42,446 (0%) | 0% | - | Common Stock | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 19,678 | 19,678 (0%) | 0% | - | Common Stock | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 19,678 | 0 | - | - | Restricted Stock Units - 2022 Award | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.10 per share. | 01 Mar 2025 | 18,138 | 41,508 (0%) | 0% | 43.1 | 781,748 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.10 per share. | 01 Mar 2025 | 15,574 | 26,872 (0%) | 0% | 43.1 | 671,239 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.10 per share. | 01 Mar 2025 | 9,146 | 10,532 (0%) | 0% | 43.1 | 394,193 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 8,400 | 374,935 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 147 | 366,534 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Sale of securities on an exchange or to another person at price $ 39.70 per share. | 04 Feb 2025 | 6,590 | 0 (0%) | 0% | 39.7 | 261,623 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Sale of securities on an exchange or to another person at price $ 39.88 per share. | 03 Feb 2025 | 8,000 | 6,590 (0%) | 0% | 39.9 | 319,080 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 153 | 360,329 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Sale of securities on an exchange or to another person at price $ 40.88 per share. | 29 Jan 2025 | 11,085 | 14,590 (0%) | 0% | 40.9 | 453,155 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Sale of securities on an exchange or to another person at price $ 40.49 per share. | 28 Jan 2025 | 20,000 | 25,675 (0%) | 0% | 40.5 | 809,800 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Sale of securities on an exchange or to another person at price $ 40.54 per share. | 27 Jan 2025 | 20,000 | 45,675 (0%) | 0% | 40.5 | 810,800 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 158 | 360,175 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 150 | 360,017 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Malady Kyle | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 152 | 359,866 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 143 | 359,714 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 143 | 359,570 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 150 | 359,426 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 145 | 353,523 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2024 | 142 | 353,378 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2024 | 136 | 353,235 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 139 | 353,098 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 148 | 352,959 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 152 | 352,811 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 149 | 352,659 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 145 | 346,893 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 148 | 346,748 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 151 | 346,599 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 147 | 346,448 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 154 | 346,300 | - | - | Phantom Stock (unitized) | |
| DexCom | Kyle Malady | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 2,613 | 18,142 (0%) | 0% | 0 | Common Stock | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 153 | 346,145 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 155 | 340,266 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2024 | 151 | 340,111 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 145 | 339,959 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 153 | 339,813 | - | - | Phantom Stock (unitized) | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 92,040 | 92,040 | - | - | Restricted Stock Units - 2024 Award | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 29,875 | 59,751 | - | - | Restricted Stock Units - 2023 Award | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 29,875 | 82,230 (0%) | 0% | - | Common Stock | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 18,420 | 18,421 | - | - | Restricted Stock Units - 2022 Award | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 18,420 | 61,344 (0%) | 0% | - | Common Stock | |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.20 per share. | 01 Mar 2024 | 16,555 | 65,675 (0%) | 0% | 40.2 | 665,511 | Common Stock |
| Verizon Communincations | Kyle Malady | EVP and Group CEO-VZ Business | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 15,085 | 50,286 (0%) | 0% | - | Common Stock |